https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/uvohm5dy/may25_cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/npjdtl1w/cp_november_cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/n2nnmblv/cover_march25.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/mvqdq2hc/nrp_cover_october_2024.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/fu1cgtla/op_0425_cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/aqbjxwjw/pp-cover.jpg
https://res.cloudinary.com/broadcastmed/image/fetch/e_unsharp_mask:70,q_auto,c_fill,f_auto,w_170,h_230/dpr_auto/https://www.ophthalmologymanagement.com/media/x1cbp0cz/cover_may25_web.jpg
Every doctor who examines the front of the eye should look for DED and treat it.
By Darrell E. White, MD
More options mean more complexity in prescribing
By Ivan Mac, MD, MBA
The evolving landscape offers unprecedented opportunities for tailored therapeutic and interventional approaches.
By Bela Parekh, MD, Jai G. Parekh, MD, MBA, FAAO
Many patients are left feeling hopeless in their search for effective symptom management.
By Marjan Farid, MD
Invest in your people, and they will invest in your practice.
By Lauren G. Lee
Not only will it serve as a tool for crafting interview questions, it also will help identify red flags that a resume may not present.
By Ruth A. Akers, SHRM-CP, CPO
Riad Sherif, MD, discusses positive data from Oculis' phase 2 ACUITY trial of OCS-05 in acute optic neuritis, the significance this neuroprotective treatment will have for patients, and more.
Features include an integrated headset and a wirelss tablet interface with voice commands.
By Karen Appold, contributing writer
Opportunities for professional development that young ophthalmologists should know are available
By Clarisa Marie Bloemhof, BS, BA, Lisa M. Nijm, MD, JD